Parathyroid hormone level in people on programmed hemodialysis

Ju Seunghwan; Said Ismailov; Zulaykho Shamansurova

doi:10.1530/endoabs.90.EP535

EP535

Prev Next

Section Contents Cite

Endocrine Abstracts (2023) 90 EP535 | DOI: 10.1530/endoabs.90.EP535

ECE2023 Eposter Presentations Diabetes, Obesity, Metabolism and Nutrition (355 abstracts)

Parathyroid hormone level in people on programmed hemodialysis

Ju Seunghwan ¹ , Said Ismailov ¹ & Zulaykho Shamansurova ^1,2

Err

Author affiliations

¹Tashkent Pediatric Medical Institute, Endocrinology with Pediatric Endocrinology, Tashkent, Uzbekistan; ²Institute Biophysics and Biochemistry at the National University of Uzbekistan, Metabolomics, Tashkent, Uzbekistan.

Introduction: The purpose of this work was monitor the frequency of determination and compare the levels of parathyroid hormone in blood plasma in people on programmed hemodialysis.

Material and methods: Data from medical records of 465 patients on programmed hemodialysis who were admitted to the Republican Centre of Nephrology and Kidney Transplantation were analyzed. Patients according to reason of end stage of renal failure were divided into 3 groups due to chronic glomerulonephritis, diabetes mellitus and other reasons.

Results: The level of glycemia was significantly higher in the group of patients with DM, the level of creatinine, urea nitrogen, calcium, phosphorus in the blood plasma was high and no differences were found between the groups. Only 15% patients on Programmed hemodialysis PTH level in blood plasma, while 48% of them have a normal range and 52% have a higher levels of hormone.

Conclusion: Determination of the PTH level in blood plasma and early diagnosis of hyperparathyroidism in people on programmed hemodialysis were performed at an insufficient level in our study. Eliminating this fault will undoubtedly help to improve the effect of treatment and increase the life expectancy of patients.